Fujifilm Philippines supports campaign to end TB

MANILA, Philippines —  Fujifilm Philippines, a global leader in imaging and healthcare technology, has expressed support for the Department of Health and United States Agency for International Development (USAID) in their campaign to end tuberculosis (TB) in the country. 2022 data from the DOH show that around 106 Filipinos die every day from TB, a severe lung infection caused by bacteria.

One of the critical contributions Fujifilm has made is providing FDR Xair, a portable X-ray system, which plays a crucial role in early TB detection by enabling healthcare professionals to conduct rapid and accurate screenings in diverse settings.

By deploying portable X-ray systems in areas across the country, Fujifilm is helping bridge healthcare access gaps and improve diagnostic capabilities.

The FDR Xair, well-known for its portability and high image quality, plays a pivotal role in enhancing TB screening efforts, particularly in remote and underserved communities where access to healthcare infrastructure is limited.

Fujifilm Philippines conducted its first Medical Mission and TB screening using their X-ray systems (FDR nano and FDR Go PLUS) in Majayjay Laguna in 2023.

The company plans to continue this program annually and utilize FDR Xair.

By working closely with affected communities, local healthcare providers, and grassroots organizations, the company ensures that TB interventions are culturally sensitive, equitable and sustainable.

Fujifilm Philippines recognizes the urgent need to enhance TB detection capabilities as cases of this infectious disease continue to surge across the country, according to the DOH.

As of Dec. 31, 2023, DOH recorded over 600,000 cases of TB, or 549 cases per 100,000 people.

This figure is higher than that of 2022, with 439 cases per 100,000 people.

Despite its lethality, TB can be cured through free medication provided at TB DOTS clinics nationwide, where patients undergo a six-month treatment regimen without interruption.